BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 27104958)

  • 1. Dexamethasone Attenuates LPS-induced Acute Lung Injury through Inhibition of NF-κB, COX-2, and Pro-inflammatory Mediators.
    Al-Harbi NO; Imam F; Al-Harbi MM; Ansari MA; Zoheir KM; Korashy HM; Sayed-Ahmed MM; Attia SM; Shabanah OA; Ahmad SF
    Immunol Invest; 2016 May; 45(4):349-69. PubMed ID: 27104958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diosmin downregulates the expression of T cell receptors, pro-inflammatory cytokines and NF-κB activation against LPS-induced acute lung injury in mice.
    Imam F; Al-Harbi NO; Al-Harbi MM; Ansari MA; Zoheir KM; Iqbal M; Anwer MK; Al Hoshani AR; Attia SM; Ahmad SF
    Pharmacol Res; 2015 Dec; 102():1-11. PubMed ID: 26361726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenuigenin ameliorates acute lung injury by inhibiting NF-κB and MAPK signalling pathways.
    Lv H; Zhu C; Liao Y; Gao Y; Lu G; Zhong W; Zheng Y; Chen W; Ci X
    Respir Physiol Neurobiol; 2015 Sep; 216():43-51. PubMed ID: 25930113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevioside protects LPS-induced acute lung injury in mice.
    Yingkun N; Zhenyu W; Jing L; Xiuyun L; Huimin Y
    Inflammation; 2013 Feb; 36(1):242-50. PubMed ID: 22968433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice.
    Tang Y; Chen Y; Chu Z; Yan B; Xu L
    Eur J Pharmacol; 2014 Jan; 723():494-500. PubMed ID: 24161915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rg3 ameliorates lipopolysaccharide-induced acute lung injury in mice through inactivating the nuclear factor-κB (NF-κB) signaling pathway.
    Cheng Z; Li L
    Int Immunopharmacol; 2016 May; 34():53-59. PubMed ID: 26921732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
    Yang S; Yu Z; Wang L; Yuan T; Wang X; Zhang X; Wang J; Lv Y; Du G
    J Ethnopharmacol; 2017 Mar; 200():147-155. PubMed ID: 28192201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Patchoulene from patchouli oil protects against LPS-induced acute lung injury via suppressing NF-κB and activating Nrf2 pathways.
    Chen XY; Dou YX; Luo DD; Zhang ZB; Li CL; Zeng HF; Su ZR; Xie JH; Lai XP; Li YC
    Int Immunopharmacol; 2017 Sep; 50():270-278. PubMed ID: 28711783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice.
    San Z; Fu Y; Li W; Zhou E; Li Y; Song X; Wang T; Tian Y; Wei Z; Yao M; Cao Y; Zhang N
    Int Immunopharmacol; 2014 Apr; 19(2):342-50. PubMed ID: 24548765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platycodin D attenuates acute lung injury by suppressing apoptosis and inflammation in vivo and in vitro.
    Tao W; Su Q; Wang H; Guo S; Chen Y; Duan J; Wang S
    Int Immunopharmacol; 2015 Jul; 27(1):138-47. PubMed ID: 25981110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
    Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
    J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginkgo biloba extracts attenuate lipopolysaccharide-induced inflammatory responses in acute lung injury by inhibiting the COX-2 and NF-κB pathways.
    Yao X; Chen N; Ma CH; Tao J; Bao JA; Zong-Qi C; Chen ZT; Miao LY
    Chin J Nat Med; 2015 Jan; 13(1):52-8. PubMed ID: 25660288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
    Jing W; Chunhua M; Shumin W
    Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effect of the Eluting Fraction of Da-Yuan-Yin Decoction on Acute Lung Injury.
    Yang Y; Chen J; Ren H; Wei L; Huang X; Li M; Yuan J; Wang L; Jiang X; Guo L; Zhang J
    Altern Ther Health Med; 2023 Jul; 29(5):242-254. PubMed ID: 37052973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of magnolol on the Toll-like receptor 4/nuclear factor κB signaling pathway in lipopolysaccharide-induced acute lung injury in mice.
    Yunhe F; Bo L; Xiaosheng F; Fengyang L; Dejie L; Zhicheng L; Depeng L; Yongguo C; Xichen Z; Naisheng Z; Zhengtao Y
    Eur J Pharmacol; 2012 Aug; 689(1-3):255-61. PubMed ID: 22683864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
    Liu J; Huang X; Hu S; He H; Meng Z
    Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chikusetsusaponin V attenuates lipopolysaccharide-induced acute lung injury in mice by modulation of the NF-κB and LXRα.
    Su K; Zhang G; Zhang X; Jiang W
    Int Immunopharmacol; 2019 May; 70():174-179. PubMed ID: 30807930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice.
    Zhong WT; Wu YC; Xie XX; Zhou X; Wei MM; Soromou LW; Ci XX; Wang DC
    Fitoterapia; 2013 Oct; 90():132-9. PubMed ID: 23751215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.